Resynchronization slows heart failure progressionBut study results leave cardiologists wrestling with questions of cost and patient selection Doubling clopidogrel dose makes for safer angioplastyDecrease in heart attack and thrombosis risk outweighs rise in severe bleeding: Canadian study New antiplatelet agent reduces cardiovascular events What are the causes and treatments for anemia of chronic disease? What are the causes and drug treatments for “anemia of chronic disease” and anemia resulting from chronic renal failure? Getting to the heart of it Community management of the post-myocardial infarction patient. Clinical Feature: Dysplipidemia A look at current issues and what’s new in management. The gender divide: heart failure differs in women Physicians should be aware of variance in symptoms, age at onset and comorbidities in female patients Ontario study reheats rosiglitazone controversy Research recommends avoiding the medication due to cardiovascular risks Dabigatran vs. warfarin in atrial fibrillation Optimal dose of ASA First Previous 83 84 85 86 87 Next Last
